Quantcast

Latest Anilides Stories

2014-10-10 08:23:54

Data from Sublingual Sufentanil Development Program Highlights Onset of Analgesia, Safety and Effect of Gender on Analgesic Response REDWOOD CITY, Calif., Oct. 10, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that multiple moderated poster presentations will be made at the upcoming American Society of Anesthesiologists (ASA 2014) meeting October 11(th) to October 15(th), 2014 at the Ernest N. Morial Convention Center in New Orleans, LA. The annual...

2014-08-18 12:25:11

WASHINGTON, Aug. 18, 2014 /PRNewswire-USNewswire/ -- Emergency physicians should expect "an upswing in what on the surface appear to be heroin overdoses," but are actually overdoses tied to acetyl fentanyl, an opiate that is mixed into street drugs marketed as heroin. The looming threat of another unregulated quasi-legal drug is detailed today online in Annals of Emergency Medicine ("The Potential Threat of Acetyl Fentanyl: Legal Issues, Contaminated Heroin, and Acetyl Fentanyl...

kidney stone
2014-08-18 03:45:20

Caroline Arbanas, Washington University in St. Louis Anyone who has suffered from kidney stones is keenly aware of the lack of drugs to treat the condition, which often causes excruciating pain. A new mouse study, however, suggests that a class of drugs approved to treat leukemia and epilepsy also may be effective against kidney stones, researchers at Washington University School of Medicine in St. Louis report. The drugs are histone deacetylase inhibitors, or HDAC inhibitors for...

2014-08-11 16:27:34

REDWOOD CITY, Calif., Aug. 11, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and six months ended June 30, 2014. On July 25, 2014, AcelRx announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Company's new...

2014-07-30 16:29:50

CUPERTINO, Calif., July 30, 2014 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2014 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, August 7, 2014 at 4:30 pm Eastern Time (1:30 pm Pacific Time). http://photos.prnewswire.com/prnvar/20020717/DRRXLOGO A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2014-06-24 12:27:59

CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process BETHESDA, Md., June 24, 2014 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation applauds the successful results of Phase 3 studies of ivacaftor (Kalydeco(TM)) in combination with lumacaftor (VX-809) for people with two copies of the F508del mutation of cystic fibrosis (CF). The results showed significant improvements in lung function and other key measures of the disease,...

2014-05-16 08:26:43

CUPERTINO, Calif., May 16, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that data for POSIDUR((TM)) (SABER(®)-Bupivacaine), an investigational drug for administration into the surgical site to produce post-surgical analgesia, is being presented at the International Anesthetic Research Society (IARS) Annual Meeting. The meeting will be held on May 17-20 at the Fairmont Queen Elizabeth Hotel in Montreal. "Bupivacaine is a widely used local anesthetic...

2014-05-01 08:35:48

REDWOOD CITY, Calif., May 1, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that multiple Zalviso and ARX-04 data presentations will be made at the American Pain Society's (APS) 33(rd) Annual Scientific Meeting held on April 30 to May 3 in Tampa, Florida. The APS Annual Scientific Meeting is the...

2014-04-23 20:23:13

CUPERTINO, Calif., April 23, 2014 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) first quarter 2014 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, May 1, 2014 at 4:30 pm Eastern Time (1:30 pm Pacific Time). http://photos.prnewswire.com/prnvar/20020717/DRRXLOGO A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2014-02-18 08:31:45

CUPERTINO, Calif., Feb. 18, 2014 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2014 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, February 27, 2014 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) In addition, on Monday, March 3, 2014 at 8:10 a.m. Eastern time, James E. Brown, President and...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.